Medical Ikkou Group Co., Ltd. (JP:3353)
:3353
3353 Stock Chart & Stats
¥2930.00
¥4.00(0.19%)
At close: 4:00 PM EST
¥2930.00
¥4.00(0.19%)
Day’s Range― - ―
52-Week Range¥2,120.00 - ¥4,410.00
Previous CloseN/A
Volume1.00K
Average Volume (3M)5.09K
Market Cap
¥9.94B
Enterprise Value¥14.55B
Total Cash (Recent Filing)¥8.60B
Total Debt (Recent Filing)¥11.43B
Price to Earnings (P/E)9.2
Beta0.38
Next Earnings
Apr 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.51%
Share Statistics
EPS (TTM)74.34
Shares Outstanding3,770,000
10 Day Avg. Volume10,430
30 Day Avg. Volume5,086
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)0.59
Price to Sales (P/S)0.17
P/FCF Ratio41.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthA 21.3% top-line increase signals durable demand expansion in the company's healthcare/pharmacy operations. Sustained revenue growth supports scale economics, funds reinvestment in network or services, and improves capacity to absorb cost shocks and finance strategic investments.
Improving MarginsSequential gross and EBIT margin improvement indicates lasting gains in cost control and operational efficiency. Consistent margin expansion enhances operating leverage, increases internal cash generation potential, and strengthens competitive positioning through better unit economics.
Healthy Solvency & Debt ManagementA robust equity ratio and a declining debt-to-equity reflect sustained solvency and prudent leverage control. This balance-sheet strength preserves financial flexibility for capex, acquisitions or downturns and lowers refinancing risk over the medium term.
Bears Say
Sharp Cash Flow DeclineA large fall in operating and free cash flow materially reduces internal funding capacity. Persistently lower cash generation can constrain capex, dividend policy, debt repayment and strategic investments, elevating refinancing and liquidity risk over the coming months.
Low Net Profit MarginA sub-3% net margin leaves limited room to absorb cost inflation or adverse revenue swings. Low net profitability constrains retained earnings and slows balance-sheet strengthening, making the business more sensitive to cyclical pressures and cost shocks.
Material Absolute Debt LevelEven with improving ratios, a sizable absolute debt stock can pressure cash flow during slower growth. Material debt increases interest and refinancing exposure, limiting strategic flexibility and heightening vulnerability if operating performance weakens.
3353 FAQ
What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?
Medical Ikkou Group Co., Ltd. lowest stock price was ¥2120.00 and its highest was ¥4410.00 in the past 12 months.
What is Medical Ikkou Group Co., Ltd.’s market cap?
Medical Ikkou Group Co., Ltd.’s market cap is ¥9.94B.
When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?
Medical Ikkou Group Co., Ltd.’s upcoming earnings report date is Apr 06, 2026 which is in 8 days.
How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?
Medical Ikkou Group Co., Ltd. released its earnings results on Jan 09, 2026. The company reported ¥74.34 earnings per share for the quarter, beating the consensus estimate of N/A by ¥74.34.
Is Medical Ikkou Group Co., Ltd. overvalued?
According to Wall Street analysts Medical Ikkou Group Co., Ltd.’s price is currently Overvalued.
Does Medical Ikkou Group Co., Ltd. pay dividends?
Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 3.51%. See more information on Medical Ikkou Group Co., Ltd. dividends here
What is Medical Ikkou Group Co., Ltd.’s EPS estimate?
Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Ikkou Group Co., Ltd. have?
Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.
What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?
Medical Ikkou Group Co., Ltd. reported an EPS of ¥74.34 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.169%.
Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3353
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical Ikkou Group Co., Ltd.
Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.
Technical Analysis
LIKE, Inc.
―
Tamagawa Holdings Co., Ltd.
―
halmek holdings Co.,Ltd.
―
I. A Group Corporation
―
People, Dreams & Technologies Group Co., Ltd.
―